FTC v. Garvey
This article was originally published in The Tan Sheet
Executive Summary
Commission files notice of appeal Jan. 23 following Los Angeles federal court's ruling that former baseball player Steve Garvey's statements about Enforma Natural Products' weight-loss supplements were not "knowingly false" or made with "reckless disregard of the truth" (1"The Tan Sheet" Nov. 11, 2002, p. 7). Appeal follows Commissioner Thomas Leary's remarks at Jan. 16 conference that FTC plans to seek consumer redress for false ad claims from endorsers...
You may also be interested in...
Enforma Spokesman Garvey Not Liable For Weight-Loss Claims – Judge
The Federal Trade Commission presented insufficient evidence to support its claim that a former baseball player's statements about the efficacy of Enforma Natural Products' weight-loss supplements were "knowingly false" or made with "reckless disregard of the truth," a federal judge has concluded
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.